New Delhi, 27 June (IANS). The team of international scientists has created a new Artificial Intelligence (AI) tool that can revolutionize the treatment of cancer.
According to the report of the news agency Xinhua, this new technology solves a major problem in treating cancer, sometimes the tumors have different types of cells, not the same, but different. This is called ‘tumor heteroseneti’. Every type of cell reacts differently to the treatment.
Some cells die of treatment, but some survive, which later leads to the return of cancer.
The AI Tool named ‘Anenet’ has been created by the Garvan Institute of Medical Research in Australia and the Yale of Medicine of the US. This tool will deeply study the genes of genes inside every cell of cancer.
The International Research Team reported that with the help of this AI toilet, 5 different types of cells were found inside the tumor. Everyone had their own different behavior and different threats to spread. In old ways, doctors used to treat all cancer cells as the same, but now this new technique can be treated better.
Garvan Institute Associate Professor Christine Chafer said, “Tumor heterogenity is a major problem, as the tumor is treated as all cells are treated as the same. Under this, we give a therapy that kills most of the tumor cells in a particular way. But not every cell can stretch the cancer from that treatment, but they do not get rid of the cancer. Helps us recognize the variety inside the tumor biologically. “
Smita Krishnaswamy, Associate Professor of Yale University, is the co-producer of this AI tool. He said that this is the first technique that can transform the complexity of cells to easily understanding types. This can lead to a huge change in the precise treatment of cancer. That is, this technique can completely change the procedural oncology.
This technique is now ready for treatment. This study, published in a journal called ‘Cancer Discovery’, also states that this technique has proved successful in breast cancer, as well as it can also be beneficial for other types of cancer and autoimmune diseases, which is a major step towards personalized medicine.
-IANS
PK/AS
